Laekna (HKSE:02105) Long-Term Capital Lease Obligation : HK$3.49 Mil (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Laekna Long-Term Capital Lease Obligation?

Laekna's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$3.49 Mil.

Laekna's quarterly Long-Term Capital Lease Obligation declined from Dec. 2023 (HK$5.54 Mil) to Jun. 2024 (HK$4.51 Mil) and declined from Jun. 2024 (HK$4.51 Mil) to Dec. 2024 (HK$3.49 Mil).

Laekna's annual Long-Term Capital Lease Obligation declined from Dec. 2022 (HK$7.44 Mil) to Dec. 2023 (HK$5.54 Mil) and declined from Dec. 2023 (HK$5.54 Mil) to Dec. 2024 (HK$3.49 Mil).

Laekna Long-Term Capital Lease Obligation Historical Data

The historical data trend for Laekna's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laekna Long-Term Capital Lease Obligation Chart

Laekna Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

29.37

7.44

5.54

3.49

Laekna Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial			7.44	6.46	5.54	4.51	3.49

Laekna (HKSE:02105) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Laekna Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Laekna's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Laekna Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laekna Inc (HKSE:02105) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3-2-467, 5 Xingbin Road (Lin Li Center), Sino-Italy Ningbo Ecological Park, Zhejiang Province, Yuyao, CHN, 201203

Website

https://www.laekna.com

Laekna Inc is a science-driven, clinical-stage biotechnology company. The company has established a comprehensive R&D infrastructure to accelerate the development of molecules from discovery to registrational trials. It has initiated one clinical trial and another five clinical trials for its Core Products LAE002 and LAE001. Among these six clinical trials, three multi-regional clinical trials (MRCTs) are designed to address medical needs in the standard of care (SOC)-resistant cancers. Laekna has two Core Products and 14 other pipeline product candidates. Core Product LAE002 is an adenosine triphosphate (ATP) competitive AKT inhibitor for the treatment of ovarian cancer, prostate cancer, breast cancer and PD-1/PD-L1 drug-resistant solid tumors.

Executives

Yu Yao Yang Ming Gu Quan Tou Zi Ji Jin You Xian Gong Si	2101 Beneficial owner
Zhong Yi Ning Bo Sheng Tai Yuan Kong Gu Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Orbimed Advisors Iii Limited	2102 Investment manager
Orbimed Asia Partners Iii, L.p.	2102 Investment manager
Orbimed Asia Gp Iii, L.p.	2102 Investment manager
Futu Trustee Limited	2301 Trustee
Lu Chris Xiangyang	2501 Other
Guo Tou Zhao Shang Tou Zi Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Xian Jin Zhi Zao Chan Ye Tou Zi Ji Jin Er Qi You Xian He Huo	2101 Beneficial owner
Laekna Wonderland Limited	2101 Beneficial owner
Shang Hai Jin Pu Yi Liao Jian Kang Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Shang Hai Jin Pu Yi Liao Jian Kang Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Gp Healthcare Capital, Inc.	2101 Beneficial owner
Liu Zeng	2201 Interest of corporation controlled by you
Ealex Llc	2101 Beneficial owner

Laekna Headlines

No Headlines